Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1928 1
1948 1
1950 1
1965 1
1970 2
1974 3
1975 12
1976 17
1977 13
1978 4
1979 2
1980 6
1981 5
1982 12
1983 17
1984 26
1985 13
1986 16
1987 13
1988 28
1989 15
1990 9
1991 23
1992 18
1993 30
1994 25
1995 25
1996 20
1997 25
1998 30
1999 31
2000 33
2001 33
2002 40
2003 32
2004 33
2005 26
2006 33
2007 32
2008 31
2009 22
2010 32
2011 29
2012 26
2013 22
2014 13
2015 12
2016 20
2017 10
2018 5
2019 8
2020 7
2021 5
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

909 results
Results by year
Filters applied: . Clear all
Page 1
Bone metastases.
Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L. Coleman RE, et al. Nat Rev Dis Primers. 2020 Oct 15;6(1):83. doi: 10.1038/s41572-020-00216-3. Nat Rev Dis Primers. 2020. PMID: 33060614 Review.
Bisphosphonates in oncology.
Coleman RE, McCloskey EV. Coleman RE, et al. Bone. 2011 Jul;49(1):71-6. doi: 10.1016/j.bone.2011.02.003. Epub 2011 Feb 21. Bone. 2011. PMID: 21320652 Review.
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.
Goyal A, Mann GB, Fallowfield L, Duley L, Reed M, Dodwell D, Coleman RE, Fakis A, Newcombe R, Jenkins V, Whitham D, Childs M, Whynes D, Keeley V, Ellis I, Fairbrother P, Sadiq S, Monson K, Montgomery A, Tan W, Vale L, Homer T, Badger H, Haines RH, Lewis M, Megias D, Nabi Z, Singh P, Caraman A, Miles E; POSNOC Trialists. Goyal A, et al. Among authors: coleman re. BMJ Open. 2021 Dec 2;11(12):e054365. doi: 10.1136/bmjopen-2021-054365. BMJ Open. 2021. PMID: 34857578 Free PMC article. Clinical Trial.
Bisphosphonates: clinical experience.
Coleman RE. Coleman RE. Oncologist. 2004;9 Suppl 4:14-27. doi: 10.1634/theoncologist.9-90004-14. Oncologist. 2004. PMID: 15459426 Free article. Review.
Endocrine aspects of bone metastases.
Hofbauer LC, Rachner TD, Coleman RE, Jakob F. Hofbauer LC, et al. Among authors: coleman re. Lancet Diabetes Endocrinol. 2014 Jun;2(6):500-12. doi: 10.1016/S2213-8587(13)70203-1. Epub 2014 Jan 24. Lancet Diabetes Endocrinol. 2014. PMID: 24880565 Review.
Potential anticancer properties of bisphosphonates.
Neville-Webbe HL, Gnant M, Coleman RE. Neville-Webbe HL, et al. Among authors: coleman re. Semin Oncol. 2010 Jun;37 Suppl 1:S53-65. doi: 10.1053/j.seminoncol.2010.06.008. Semin Oncol. 2010. PMID: 20682373 Review.
Bisphosphonates in breast cancer.
Coleman RE. Coleman RE. Ann Oncol. 2005 May;16(5):687-95. doi: 10.1093/annonc/mdi162. Epub 2005 Mar 31. Ann Oncol. 2005. PMID: 15802276 Free article. Review.
PET evaluation of lung cancer.
Bunyaviroch T, Coleman RE. Bunyaviroch T, et al. Among authors: coleman re. J Nucl Med. 2006 Mar;47(3):451-69. J Nucl Med. 2006. PMID: 16513615 Free article. Review. No abstract available.
909 results